Back to Top
Tobevibart Biosimilar - Research Grade
$710.00 - $6,900.00
Tobevibart Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
HBVï؟½
Concentration
5mg/ml
Isotype
IgG1 - lambda2
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
Hepatitis B virus surface antigens are central to viral entry and persistence, making them important targets in antiviral research. The reagent here is a research-grade, unconjugated analog of tobevibart, a recombinant monoclonal antibody recognizing HBV, for research use only. It is produced to in vivo standards in a low-endotoxin format and supplied in scalable milligram to gram quantities for high-throughput laboratories. Applications include viral neutralization functional assays, in vitro surface-antigen binding screens, and in vivo models investigating hepatitis B infection and clearance. Its purity and dependable supply support reproducible work in demanding, high-throughput settings.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review













